IBDEI0LB ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1676,0)
 ;;="L" MISC DIAGNOSIS^49^183
 ;;^UTILITY(U,$J,358.4,1677,0)
 ;;="M" MISC DIAGNOSIS^51^183
 ;;^UTILITY(U,$J,358.4,1678,0)
 ;;="N" MISC DIAGNOSIS^59^183
 ;;^UTILITY(U,$J,358.4,1679,0)
 ;;="P" MISC DIAGNOSIS^65^183
 ;;^UTILITY(U,$J,358.4,1680,0)
 ;;="X" MISC DIAGNOSIS^75^183
 ;;^UTILITY(U,$J,358.4,1681,0)
 ;;="V" MISC DIAGNOSIS^72^183
 ;;^UTILITY(U,$J,358.4,1682,0)
 ;;="W" MISC DIAGNOSIS^74^183
 ;;^UTILITY(U,$J,358.4,1683,0)
 ;;=AFTERCARE CODES^0^183
 ;;^UTILITY(U,$J,358.4,1684,0)
 ;;="S" MISC DIAGNOSIS^67^183
 ;;^UTILITY(U,$J,358.4,1685,0)
 ;;=CANCER (NOT MELANOMA)^6.5^183
 ;;^UTILITY(U,$J,358.4,1686,0)
 ;;=BOIL/FURUNCLE^5.5^183
 ;;^UTILITY(U,$J,358.4,1687,0)
 ;;=CHEILITIS^8.03^183
 ;;^UTILITY(U,$J,358.4,1688,0)
 ;;=CYST^8.07^183
 ;;^UTILITY(U,$J,358.4,1689,0)
 ;;=DRUG REACTION^10.02^183
 ;;^UTILITY(U,$J,358.4,1690,0)
 ;;=LENTIGO^45^183
 ;;^UTILITY(U,$J,358.4,1691,0)
 ;;="O" DIAGNOSES^60^183
 ;;^UTILITY(U,$J,358.4,1692,0)
 ;;=PSYCHO CUTEANOUS DERMATITIS^64.5^183
 ;;^UTILITY(U,$J,358.4,1693,0)
 ;;="R" DIAGNOSES^65.5^183
 ;;^UTILITY(U,$J,358.4,1694,0)
 ;;="T" DIAGNOSES^67.5^183
 ;;^UTILITY(U,$J,358.4,1695,0)
 ;;=SCREENING^65.6^183
 ;;^UTILITY(U,$J,358.4,1696,0)
 ;;=NEOPLASM-MALIGNANT^55^183
 ;;^UTILITY(U,$J,358.4,1697,0)
 ;;=TELEHEALTH FACILITY FEE^1^184
 ;;^UTILITY(U,$J,358.4,1698,0)
 ;;=TELERETINAL PROCEDURES^1^185
 ;;^UTILITY(U,$J,358.4,1699,0)
 ;;=ORBIT/EYELID/LACRIMAL^8^186
 ;;^UTILITY(U,$J,358.4,1700,0)
 ;;=ANTERIOR SEGMENT/LACRIMAL^2^186
 ;;^UTILITY(U,$J,358.4,1701,0)
 ;;=LENS/CATARACT^5^186
 ;;^UTILITY(U,$J,358.4,1702,0)
 ;;=RETINA/VITREOUS/CHOROID^9^186
 ;;^UTILITY(U,$J,358.4,1703,0)
 ;;=NEUROLOGIC EYE DISEASE^7^186
 ;;^UTILITY(U,$J,358.4,1704,0)
 ;;=MEDICAL/SYSTEMIC/TRAUMA/OTHER^6^186
 ;;^UTILITY(U,$J,358.4,1705,0)
 ;;=GLAUCOMA^3^186
 ;;^UTILITY(U,$J,358.4,1706,0)
 ;;=STRABISMUS^10^186
 ;;^UTILITY(U,$J,358.4,1707,0)
 ;;=INFECTIONS/INFLAMMATION/CONJUNCTIVA^4^186
 ;;^UTILITY(U,$J,358.4,1708,0)
 ;;=MOST COMMON^1^186
 ;;^UTILITY(U,$J,358.4,1709,0)
 ;;=MALE URETHRAL DILATION^3^187
 ;;^UTILITY(U,$J,358.4,1710,0)
 ;;=MISCELLANEOUS^4^187
 ;;^UTILITY(U,$J,358.4,1711,0)
 ;;=URODYNAMICS^5^187
 ;;^UTILITY(U,$J,358.4,1712,0)
 ;;=ZOLADEX^6^187
 ;;^UTILITY(U,$J,358.4,1713,0)
 ;;=CYSTOURETHROSCOPY^1^187
 ;;^UTILITY(U,$J,358.4,1714,0)
 ;;=FEMALE ONLY PROCEDURES^2^187
 ;;^UTILITY(U,$J,358.4,1715,0)
 ;;=UNLISTED UROLOGY PROCEDURES^7^187
 ;;^UTILITY(U,$J,358.4,1716,0)
 ;;=NEW PATIENT^2^188
 ;;^UTILITY(U,$J,358.4,1717,0)
 ;;=ESTABLISHED PATIENT^1^188
 ;;^UTILITY(U,$J,358.4,1718,0)
 ;;=CONSULTATIONS^3^188
 ;;^UTILITY(U,$J,358.4,1719,0)
 ;;=POST OP VISIT (GLOBAL)^4^188
 ;;^UTILITY(U,$J,358.4,1720,0)
 ;;=OTHER E&M SERVICES^5^188
 ;;^UTILITY(U,$J,358.4,1721,0)
 ;;=NEURO-UROLOGY^15^189
 ;;^UTILITY(U,$J,358.4,1722,0)
 ;;=BLADDER^1^189
 ;;^UTILITY(U,$J,358.4,1723,0)
 ;;=KIDNEY/URETER^8^189
 ;;^UTILITY(U,$J,358.4,1724,0)
 ;;=PENIS/EXTERNAL GENITALIA^16^189
 ;;^UTILITY(U,$J,358.4,1725,0)
 ;;=PROSTATE^18^189
 ;;^UTILITY(U,$J,358.4,1726,0)
 ;;=POST OP^17^189
 ;;^UTILITY(U,$J,358.4,1727,0)
 ;;=MISCELLANEOUS/SYMPTOMS^10^189
 ;;^UTILITY(U,$J,358.4,1728,0)
 ;;=MISC/CONDITIONS/STATES^9^189
 ;;^UTILITY(U,$J,358.4,1729,0)
 ;;=INFECTIONS-VENEREAL^7^189
 ;;^UTILITY(U,$J,358.4,1730,0)
 ;;=INFECTIONS-RENAL/URETER^6^189
 ;;^UTILITY(U,$J,358.4,1731,0)
 ;;=INFECTIONS-PROSTATE^5^189
 ;;^UTILITY(U,$J,358.4,1732,0)
 ;;=INFECTIONS-KIDNEY^4^189
 ;;^UTILITY(U,$J,358.4,1733,0)
 ;;=INFECTION-MISCELLANEOUS^3^189
 ;;^UTILITY(U,$J,358.4,1734,0)
 ;;=NEOPLASIA-BLADDER/URETHRA^11^189
 ;;^UTILITY(U,$J,358.4,1735,0)
 ;;=NEOPLASIA-PROSTATE^14^189
 ;;^UTILITY(U,$J,358.4,1736,0)
 ;;=NEOPLASIA-KIDNEY/URETER^13^189
 ;;^UTILITY(U,$J,358.4,1737,0)
 ;;=NEOPLASIA-EXTERNAL GENITALIA^12^189
 ;;^UTILITY(U,$J,358.4,1738,0)
 ;;=COMPLICATIONS^2^189
 ;;^UTILITY(U,$J,358.4,1739,0)
 ;;=NEW PATIENT^2^190
 ;;^UTILITY(U,$J,358.4,1740,0)
 ;;=ESTABLISHED PATIENT^1^190
 ;;^UTILITY(U,$J,358.4,1741,0)
 ;;=CONSULTATIONS^3^190
 ;;^UTILITY(U,$J,358.4,1742,0)
 ;;=RESPIRATORY^8^191
 ;;^UTILITY(U,$J,358.4,1743,0)
 ;;=CARDIOVASCULAR^4^191
 ;;^UTILITY(U,$J,358.4,1744,0)
 ;;=ABDOMINAL PAIN^2^191
 ;;^UTILITY(U,$J,358.4,1745,0)
 ;;=AFTERCARE POST SURGERY^3^191
 ;;^UTILITY(U,$J,358.4,1746,0)
 ;;=COMMON VASCULAR DX^1^191
 ;;^UTILITY(U,$J,358.4,1747,0)
 ;;=POST-OP COMPLICATIONS^7^191
 ;;^UTILITY(U,$J,358.4,1748,0)
 ;;=METASTATIC CANCER SITES^6^191
 ;;^UTILITY(U,$J,358.4,1749,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^5^191
 ;;^UTILITY(U,$J,358.4,1750,0)
 ;;=DEBRIDEMENT^2^192
 ;;^UTILITY(U,$J,358.4,1751,0)
 ;;=I&D/ASPIRATION^3^192
 ;;^UTILITY(U,$J,358.4,1752,0)
 ;;=UNNA BOOT^4^192
 ;;^UTILITY(U,$J,358.4,1753,0)
 ;;=PEG TUBE^5^192
 ;;^UTILITY(U,$J,358.4,1754,0)
 ;;=WOUND VAC DRESSING^6^192
 ;;^UTILITY(U,$J,358.4,1755,0)
 ;;=VASCULAR PROCEDURES^1^192
 ;;^UTILITY(U,$J,358.4,1756,0)
 ;;=GYN PROCEDURES^1^193
 ;;^UTILITY(U,$J,358.4,1757,0)
 ;;=INJECTIONS^11^193
 ;;^UTILITY(U,$J,358.4,1758,0)
 ;;=ADMINISTRATION OF INJECTION^10^193
 ;;^UTILITY(U,$J,358.4,1759,0)
 ;;=EAR WAX REMOVAL^5^193
 ;;^UTILITY(U,$J,358.4,1760,0)
 ;;=CARDIAC^2^193
 ;;^UTILITY(U,$J,358.4,1761,0)
 ;;=FOREIGN BODY^8^193
 ;;^UTILITY(U,$J,358.4,1762,0)
 ;;=UA/FINGERSTICK^13^193
 ;;^UTILITY(U,$J,358.4,1763,0)
 ;;=FLUSHES^6^193
 ;;^UTILITY(U,$J,358.4,1764,0)
 ;;=TB TEST^12^193
 ;;^UTILITY(U,$J,358.4,1765,0)
 ;;=DRAIN/INJECT JOINT^4^193
 ;;^UTILITY(U,$J,358.4,1766,0)
 ;;=DESTRUCTION OF LESIONS^3^193
 ;;^UTILITY(U,$J,358.4,1767,0)
 ;;=IMMUNIZATIONS^9^193
 ;;^UTILITY(U,$J,358.4,1768,0)
 ;;=ADMINISTRATION OF IMMUNIZATIONS^8^193
 ;;^UTILITY(U,$J,358.4,1769,0)
 ;;=NEW PATIENT^2^194
 ;;^UTILITY(U,$J,358.4,1770,0)
 ;;=ESTABLISHED PATIENT^1^194
 ;;^UTILITY(U,$J,358.4,1771,0)
 ;;=CONSULTATIONS^3^194
 ;;^UTILITY(U,$J,358.4,1772,0)
 ;;=POST-OP F/U VISIT^5^194
 ;;^UTILITY(U,$J,358.4,1773,0)
 ;;=HEALTHY/PREVENTIVE VISIT^4^194
 ;;^UTILITY(U,$J,358.4,1774,0)
 ;;=CARDIO/VASCULAR^2^195
 ;;^UTILITY(U,$J,358.4,1775,0)
 ;;=ENDOCRINE, METOBOLIC, NUTRITIONAL^3^195
 ;;^UTILITY(U,$J,358.4,1776,0)
 ;;=EYES, EARS, & NOSE^4^195
 ;;^UTILITY(U,$J,358.4,1777,0)
 ;;=GASTROINTESTINAL^5^195
 ;;^UTILITY(U,$J,358.4,1778,0)
 ;;=GENITOURINARY & RENAL^6^195
 ;;^UTILITY(U,$J,358.4,1779,0)
 ;;=MUSCULOSKETAL^7^195
 ;;^UTILITY(U,$J,358.4,1780,0)
 ;;=NEUROLOGY^8^195
 ;;^UTILITY(U,$J,358.4,1781,0)
 ;;=PULMONARY/RESPIRATORY^9^195
 ;;^UTILITY(U,$J,358.4,1782,0)
 ;;=PSYCHIATRIC^10^195
 ;;^UTILITY(U,$J,358.4,1783,0)
 ;;=SKIN^11^195
 ;;^UTILITY(U,$J,358.4,1784,0)
 ;;=GYNECOLOGICAL/BREAST^1^195
 ;;^UTILITY(U,$J,358.4,1785,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^.5^195
 ;;^UTILITY(U,$J,358.4,1786,0)
 ;;=IMMUNIZATIONS^12^195
 ;;^UTILITY(U,$J,358.4,1787,0)
 ;;=WOUND OSTOMY CARE^1^196
 ;;^UTILITY(U,$J,358.4,1788,0)
 ;;=WOUNDS^1^197
 ;;^UTILITY(U,$J,358.4,1789,0)
 ;;=ARTIFICIAL OPENING^2^197
 ;;^UTILITY(U,$J,358.4,1790,0)
 ;;=DIABETES^3^197
 ;;^UTILITY(U,$J,358.4,1791,0)
 ;;=PRESSURE ULCER^4^197
 ;;^UTILITY(U,$J,358.4,1792,0)
 ;;=STAGE OF PRESSURE ULCER^5^197
 ;;^UTILITY(U,$J,358.4,1793,0)
 ;;=SUTURE/DRESSING^6^197
 ;;^UTILITY(U,$J,358.4,1794,0)
 ;;=NEW PATIENT^2^198
 ;;^UTILITY(U,$J,358.4,1795,0)
 ;;=ESTABLISHED PATIENT^1^198
 ;;^UTILITY(U,$J,358.4,1796,0)
 ;;=IMMUNIZATIONS/INJECTIONS^4^199
 ;;^UTILITY(U,$J,358.4,1797,0)
 ;;=RESPIRATORY^8^199
 ;;^UTILITY(U,$J,358.4,1798,0)
 ;;=SLEEP STUDIES^9^199
 ;;^UTILITY(U,$J,358.4,1799,0)
 ;;=PULMONARY FUNCTION TESTS^7^199
 ;;^UTILITY(U,$J,358.4,1800,0)
 ;;=OTHER^5^199
 ;;^UTILITY(U,$J,358.4,1801,0)
 ;;=ABG^1^199
 ;;^UTILITY(U,$J,358.4,1802,0)
 ;;=OXYGEN CLINIC^6^199
 ;;^UTILITY(U,$J,358.4,1803,0)
 ;;=CPAP^2^199
 ;;^UTILITY(U,$J,358.4,1804,0)
 ;;=EDUCATION/TRAINING GRP/IND^3^199
 ;;^UTILITY(U,$J,358.4,1805,0)
 ;;=PULMONARY DIAGNOSES^1^200
 ;;^UTILITY(U,$J,358.4,1806,0)
 ;;=SLEEP DISORDER DIAGNOSES^2^200
 ;;^UTILITY(U,$J,358.4,1807,0)
 ;;=OTHER^3^200
